Successful 10-year Eurobond issue for Mölnlycke

Mölnlycke, a world-leading medical solutions company, successfully launched on 2 December a EUR 400 million senior unsecured bond under its EMTN (Euro Medium Term Note) programme. The bond has a 10-year tenor with an annual fixed coupon of 0,6250% and a yield of 0,6330%. Mölnlycke prints with the lowest yield ever achieved on a 10-year EUR senior unsecured bond issued by a BBB- rated corporate.

There was strong and widespread investor demand for the bond issue, which was more than two times oversubscribed.

The proceeds will be used for a simultaneous buy-back of part of Mölnlycke notes maturing in 2022 and for general corporate purposes. The transaction has enabled Mölnlycke to extend its debt maturity profile and lock in favourable financing conditions to support the Group’s continued growth. The company will stay within its financial leverage policy after the bond issue.

Demand came from leading investors in all regions: Germany/Austria/Switzerland 36%, the Nordics 30%, UK/Ireland 13%, France 11%, BeNeLux 8% and Other 2%. Asset managers were the leading investor type with 65%, followed by insurance/pension funds with 31%, while banks contributed with 4%.

For more information, please contact Susanne Larsson, CFO, +46 31 722 34 66

About Mölnlycke

Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. Mölnlycke design and supply products and solutions for use in wound treatment, pressure ulcer and infection prevention and surgery. The products and solutions provide value for money supported by clinical and health economic evidence.

Mölnlycke employs around 8,000 people and is owned by Patricia Industries, a part of Investor AB
. Mölnlycke’s headquarters are in Gothenburg, Sweden, and the company operates in more than 100 countries worldwide. Since 2007, the company belongs to Investor AB, the leading owner of Nordic-based international companies, founded by the Wallenberg family more than hundred years ago. For more information, please visit

About Us

Mölnlycke is a world-leading medical solutions company. We design and supply solutions to enhance performance at every point of care – from the hospital to the home. We specialise in solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Our products are available in approximately 100 countries worldwide. Mölnlycke was founded in 1849. Our headquarters are in Gothenburg, Sweden and we employ around 7,500 people. Since 2007, we belong to Investor AB, the leading owner of Nordic-based international companies.